Literature DB >> 620205

Tardive dyskinesia associated with metoclopramide.

S Lavy, E Melamed, S Penchas.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 620205      PMCID: PMC1602611          DOI: 10.1136/bmj.1.6105.77

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  5 in total

1.  Letter: Metoclopramide and facial dyskinesia.

Authors:  S Melmed; H Bank
Journal:  Br Med J       Date:  1975-02-08

2.  Dystonic reactions due to metoclopramide and phenothiazines resembling tetanus.

Authors:  D L Cochlin
Journal:  Br J Clin Pract       Date:  1974-06

3.  The pharmacology of tardive dyskinesias.

Authors:  H L Klawans
Journal:  Am J Psychiatry       Date:  1973-01       Impact factor: 18.112

4.  Dystonic reactions in children caused by metoclopramide.

Authors:  M Casteels-Van Daele; J Jaeken; P Van der Schueren; P Van den Bon
Journal:  Arch Dis Child       Date:  1970-02       Impact factor: 3.791

5.  Pharmacological evidence for cerebral dopamine receptor blockade by metoclopramide in rodents.

Authors:  A Dolphin; P Jenner; C D Marsden; C Pycock; D Tarsy
Journal:  Psychopharmacologia       Date:  1975
  5 in total
  16 in total

1.  Tardive dyskinesia associated with metoclopramide.

Authors:  L Beuclair; R Fontaine
Journal:  CMAJ       Date:  1986-03-15       Impact factor: 8.262

2.  The effect of metoclopramide and haloperidol on tardive dyskinesia [proceedings].

Authors:  D N Bateman; D K Dutta; H A McClelland; M D Rawlins
Journal:  Br J Pharmacol       Date:  1979-07       Impact factor: 8.739

3.  Metoclopramide and tardive dyskinesia in the elderly.

Authors:  M L Orme; R C Tallis
Journal:  Br Med J (Clin Res Ed)       Date:  1984-08-18

4.  The pharmacokinetics of single doses of metoclopramide in renal failure.

Authors:  D N Bateman; R Gokal; T R Dodd; P G Blain
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

5.  Pharmacokinetics of metoclopramide intravenously and orally determined by liquid chromatography.

Authors:  C Graffner; P O Lagerström; P Lundborg; O Rönn
Journal:  Br J Clin Pharmacol       Date:  1979-11       Impact factor: 4.335

6.  Tiapride in levodopa-induced involuntary movements.

Authors:  A J Lees; C M Lander; G M Stern
Journal:  J Neurol Neurosurg Psychiatry       Date:  1979-04       Impact factor: 10.154

7.  A double blind trial of sulpiride in Huntington's disease and tardive dyskinesia.

Authors:  N Quinn; C D Marsden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-08       Impact factor: 10.154

Review 8.  Clinical pharmacokinetics of metoclopramide.

Authors:  D N Bateman
Journal:  Clin Pharmacokinet       Date:  1983 Nov-Dec       Impact factor: 6.447

9.  Dystonic reactions and the pharmacokinetics of metoclopramide in children.

Authors:  D N Bateman; A W Craft; E Nicholson; A D Pearson
Journal:  Br J Clin Pharmacol       Date:  1983-05       Impact factor: 4.335

10.  Effects of tiapride in tardive dyskinesia.

Authors:  P Pollak; J M Gaio; M Hommel; J Pellat; J Perret
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.